Cargando…

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Latrepirdine (Dimebon(TM)) was originally marketed as a non-selective antihistamine in Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's disease (AD) and Huntington's disease (HD) following preliminary reports showing its neuroprotective functions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharadwaj, P R, Bates, K A, Porter, T, Teimouri, E, Perry, G, Steele, J W, Gandy, S, Groth, D, Martins, R N, Verdile, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030329/ https://www.ncbi.nlm.nih.gov/pubmed/24301650 http://dx.doi.org/10.1038/tp.2013.97

Ejemplares similares

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
por: Steele, John W., et al.
Publicado: (2012)

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
por: Steele, John W, et al.
Publicado: (2009)

Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer’s Disease
por: Eckert, Schamim H, et al.
Publicado: (2018)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
por: Verdile, Giuseppe, et al.
Publicado: (2006)

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability
por: Weisová, P, et al.
Publicado: (2013)

Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon(®))
por: Gorin, Boris I., et al.
Publicado: (2023)

Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
por: Cornec, Anne-Sophie, et al.
Publicado: (2017)

A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice
por: Chaprov, Kirill, et al.
Publicado: (2021)

Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006)

Nanoimaging for Molecular Pharmaceutics of Alzheimer’s and other Neurodegenerative Disorders
por: Lyubchenko, Yuri L
Publicado: (2013)

Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents
por: Voggu, Ramakrishna, et al.
Publicado: (2023)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders 2013
por: Squitti, Rosanna, et al.
Publicado: (2013)

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Doustar, Jonah, et al.
Publicado: (2017)

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
por: Cai, Qian, et al.
Publicado: (2020)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases
por: Wang, Hui, et al.
Publicado: (2023)

Molecular Hydrogen as an Emerging Therapeutic Medical Gas for Neurodegenerative and Other Diseases
por: Ohno, Kinji, et al.
Publicado: (2012)

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
por: Jayatunga, Dona Pamoda W., et al.
Publicado: (2021)

Possible Role of the Transglutaminases in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases
por: Martin, Antonio, et al.
Publicado: (2011)

Ultra-Early Phase pathologies of Alzheimer’s disease and other neurodegenerative diseases
por: OKAZAWA, Hitoshi
Publicado: (2017)

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
por: Woodfield, Amy, et al.
Publicado: (2022)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Czubowicz, Kinga, et al.
Publicado: (2019)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Oliver, Darryll, et al.
Publicado: (2019)

Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease
por: Colligris, Pade, et al.
Publicado: (2018)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies
por: Squitti, Rosanna, et al.
Publicado: (2011)

Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases
por: Alexander, Adanna G., et al.
Publicado: (2014)

Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
por: Gamache, Julia, et al.
Publicado: (2020)

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Carlson, George A., et al.
Publicado: (2021)

DNA Methylation: A Promising Approach in Management of Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Kaur, Gagandeep, et al.
Publicado: (2022)

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
por: Azizi, Zahra, et al.
Publicado: (2022)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease
por: Venkataraman, Lalitha, et al.
Publicado: (2020)

Evaluation of Virtual Screening Strategies for the Identification of γ-Secretase Inhibitors and Modulators
por: Ioppolo, Alicia, et al.
Publicado: (2021)

Mitochondria and Other Organelles in Neural Development and Their Potential as Therapeutic Targets in Neurodegenerative Diseases
por: Zhang, Shuyuan, et al.
Publicado: (2022)

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
por: Han, Dong, et al.
Publicado: (2020)

Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease
por: Verdile, Giuseppe, et al.
Publicado: (2015)

The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics
por: de la Torre, Cristina, et al.
Publicado: (2018)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8l6omp2bpuljahgb9tc4t00n57